Springboard Enterprises

LS 2013

Life Science 2013

 About Life Science: 2013

The Springboard: Life Science 2013 program featured 10 of the most promising high-growth, women-led companies in the life sciences. The Bootcamp was held on June 20, 2013 at The George Washington University in Washington, DC showcasing the entrepreneurs before an audience of the area’s top corporate, angel, and venture investors.

Committees

Alumnae Committee

  • Pamela Contag, Cygnet Biofuels

  • Sheila DeWitt, DeuteRX, LLC

  • Joan Fallon, Curemark, LLC

  • Sharon Flank, InfraTrac

  • Barbara Fox, Avaxia Biologics

  • Barbara Handelin, Bipontis Alliance

  • Irene Hrusovsky, BELLE Capital USA

  • Mary Wallace Jaensch, Semprae Laboratories

  • Heather Keith, Stroll Medical Technologies, Inc.

  • Roberta Lee, Acueity Healthcare, Inc.

  • Annette McClellan, BioMedical Engineering Solutions

  • Julia O’Connor, Accelalox Inc.

  • Nancy Parenteau, Parenteau BioConsultants

  • Gitte Pedersen, Genomic Expression

  • Diana Pilura, ALBRY

  • Yael Schwartz, Hygeia Therapeutics, Inc.

  • Laurie Smaldone, PharmApprove

  • Laura Strong, Quintessence Biosciences

  • Alexis Traynor-Kaplan, ISM Therapeutics

  • Liat Tsoref, Slender Medical

  • Jacqueline Thong, Ubiqui Health, Inc.

Screening Committee

  • Faz Bashi, Life Science Angels

  • Jenn Baumann, InnerWorkings, Inc.

  • Cathlin Bowman Young, American Society of Nuclear Cardiology

  • Corinne Bright, OnSet Ventures

  • Cheryl Buxton, Korn/Ferry International

  • Maxine Champion, Champion Strategies

  • Pravin Chaturvedi, IndUS Pharmaceuticals

  • Allan H. Cohen, First Analysis

  • Ellen Corenswet, Covington & Burling LLP

  • Eva Kramer, SUNY Downstate Medical Center

  • Mary Cummins, Aging 2.0

  • Marina Dedes, Lightbank

  • Jona Donaldson, MedDevice LLC

  • Gina Durham, DLA Piper

  • Bunny Ellerin, NYC Health Business Leaders

  • Jennifer Friel Goldstein, Silicon Valley Bank

  • Phillip Gager, Square One Bank

  • Richard Gervase, Mintz Levin

  • Greg Grossman, DLA Piper

  • Barbara Handelin,BioPontis Alliance LLC

  • Elaine Heron, Amplyx Pharmaceuticals

  • Eva Jack, Macava Consulting

  • Chris Kim, Oxford Bioscience Partners

  • Ron Kirschner, Heartland Angels

  • Jon Kravetz. Mintz Levin

  • Maryann Kuzel, MAK Associates

  • Maggie LeFlore, AesRX

  • Svetlana Lucas, Onyx Pharmaceuticals

  • Emily Levy, Synergy Partners

  • Robert Mashal, NKT Therapeutics

  • Annette McClellan, BioMedical Emerging Solutions

  • Lindsay Meyer, Canaan Partners

  • Patrick Morand, Open Prairie Ventures

  • Ingrid Rechtin, Covington & Burling LLP

  • Lily Rin-Laures, M.D., Marshall, Gerstein, Borun

  • Liz Rockett, Imprint Capital

  • Scott Samuels, Mintz Levin

  • Barbara Schmidt-Kemp, North Star Consultants

  • Yael Schwartz, Hygeria Therapeutics

  • Kay Schwichtenberg, Central Life Sciences

  • Stacey Seltzer, Aisling Capital

  • Erika Smith, Rock Spring Ventures

  • Karen Spilizewski, RiverVest Venture Partners

  • Lilian Stern, Stern Investor Relations

  • Laurance Stuntz, Massachusetts eHealth Institute

  • Mary Wallace Jaensch, SPARK Solutions for Growth

  • Tracy Warren, Battelle Ventures

  • Henry Wei, Aetna

  • Phyllis Whiteley, Didimi

  • Barbara Wood, Wood Legal

  • Alex Zisson, Thomas, McNerney & Partners